Literature DB >> 7241160

The clinical relevance of ferritin concentration in the cerebrospinal fluid.

C J Sindic, D Collet-Cassart, C L Cambiaso, P L Masson, E C Laterre.   

Abstract

By means of a new technique (Particle Counting Immunoassay), we have determined the level of ferritin in 470 samples of cerebrospinal fluid of patients with various neurological disorders. The median value obtained in a control group was 2.3 ng/ml with an upper limit at 5.5 ng/ml. the concentrations in the serum and cerebrospinal fluid were independent, but that in cerebrospinal fluid correlated with its total protein content. High values of ferritin were found in infectious meningo-encephalitis, in vascular diseases of the central nervous system, and, unexpectedly, in several cases of dementia without obvious vascular pathology.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241160      PMCID: PMC490956          DOI: 10.1136/jnnp.44.4.329

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

Review 1.  Ferritin in serum. Clinical and biochemical implications.

Authors:  A Jacobs; M Worwood
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Determination of total protein in spinal fluid with sulphosalicylic acid and trichloroacetic acid.

Authors:  O MEULEMANS
Journal:  Clin Chim Acta       Date:  1960-09       Impact factor: 3.786

3.  The non-haemin iron in the cerebral cortex in Alzheimer's disease.

Authors:  B HALLGREN; P SOURANDER
Journal:  J Neurochem       Date:  1960-06       Impact factor: 5.372

4.  Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis.

Authors:  L GOODMAN
Journal:  J Nerv Ment Dis       Date:  1953-08       Impact factor: 2.254

5.  Particle counting immunoassay (PACIA). I. A general method for the determination of antibodies, antigens, and haptens.

Authors:  C L Cambiaso; A E Leek; F De Steenwinkel; J Billen; P L Masson
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

6.  Particle counting immunoassay. IV. The use of F(ab')2 fragments and N epsilon-chloroacetyl lysine N-carboxyanhydride for their coupling to polystyrene latex particles.

Authors:  J N Limet; C H Moussebois; C L Cambiaso; J P Vaerman; P L Masson
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

7.  Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding.

Authors:  R Hällgren; A Terent; L Wide; K Bergström; G Birgegård
Journal:  Acta Neurol Scand       Date:  1980-06       Impact factor: 3.209

  7 in total
  10 in total

Review 1.  Spectrophotometry for cerebrospinal fluid pigment analysis.

Authors:  Axel Petzold; Lindsay T Sharpe; Geoffrey Keir
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis.

Authors:  Y Sato; Y Honda; T Asoh; K Oizumi; Y Ohshima; E Honda
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

Review 3.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

4.  Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.

Authors:  F Deisenhammer; R F Miller; N S Brink; M J Harrison; E J Thompson
Journal:  Genitourin Med       Date:  1997-06

5.  HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?

Authors:  Andrea Regner; Ottomar Bianchini; Claudio Jardim; Marcio Menna-Barreto
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

6.  Ferritin in cerebrospinal fluid differentiation between central nervous system haemorrhage and traumatic spinal puncture.

Authors:  M Wick; W Fink; W Pfister; K Einhäupl; M Huber; A Fateh-Moghadam
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

7.  Ferritin is secreted via 2 distinct nonclassical vesicular pathways.

Authors:  Marianna Truman-Rosentsvit; Dina Berenbaum; Lior Spektor; Lyora A Cohen; Shirly Belizowsky-Moshe; Lena Lifshitz; Jing Ma; Wei Li; Ellina Kesselman; Inbal Abutbul-Ionita; Dganit Danino; Lucia Gutierrez; Huihui Li; Kuanyu Li; Huifang Lou; Maria Regoni; Maura Poli; Fabian Glaser; Tracey A Rouault; Esther G Meyron-Holtz
Journal:  Blood       Date:  2017-10-26       Impact factor: 22.113

Review 8.  Malignancy markers in the cerebrospinal fluid.

Authors:  M Koskiniemi
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

9.  Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid.

Authors:  C J Sindic; M P Chalon; C L Cambiaso; E C Laterre; P L Masson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

10.  Bilirubin, ferritin, D-dimers and erythrophages in the cerebrospinal fluid of patients with suspected subarachnoid haemorrhage but negative computed tomography scans.

Authors:  K B Page; S J Howell; C M Smith; D J Dabbs; R G Malia; N R Porter; K J Thickett; G M Wilkinson
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.